Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/28/1996 | WO1996009391A2 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
03/28/1996 | WO1996009388A1 Novel anti-vh3-15 reagents, vh3-15 polypeptides, cell surface antigens, and methods for their detection and use |
03/28/1996 | WO1996009386A2 Allelic variation of the serotonin 5ht2c receptor |
03/28/1996 | WO1996009325A1 Modified radioantibody fragments for reduced renal uptake |
03/28/1996 | WO1996009321A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
03/28/1996 | WO1996009317A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
03/28/1996 | WO1996009311A1 Human transcription factor iia |
03/28/1996 | WO1996009067A1 Osteoclast-specific glycoprotein for diagnosis and treatment of osteoporosis |
03/28/1996 | WO1996009066A2 Method of treatment of human immunodeficiency virus (hiv) infection |
03/28/1996 | WO1996009043A1 Methods for the treatment of inflammatory joint disease |
03/28/1996 | CA2200724A1 Human galactokinase gene |
03/28/1996 | CA2200583A1 Human galactokinase gene |
03/28/1996 | CA2200434A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops |
03/28/1996 | CA2200354A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
03/28/1996 | CA2200329A1 Novel anti-vh3-15 reagents, vh3-15 polypeptides, cell surface antigens, and methods for their detection and use |
03/28/1996 | CA2199470A1 Allelic variation of the serotonin 5ht2c receptor |
03/27/1996 | EP0702960A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
03/27/1996 | EP0702793A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
03/27/1996 | EP0702730A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
03/27/1996 | EP0702726A1 Immunoassay reagents and methods for detecting brequinar and analogs |
03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
03/27/1996 | EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
03/27/1996 | EP0702720A1 Method for defined deletions of dna |
03/27/1996 | EP0702693A1 Tandem synthetic hiv-1 peptides |
03/27/1996 | EP0702689A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
03/27/1996 | EP0702563A1 Compositions and methods for treating cancer and hyperproliferative disorders |
03/27/1996 | EP0702516A1 Genetic immunization with cationic lipids |
03/27/1996 | CN1119457A Bone stimulating factor |
03/27/1996 | CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
03/26/1996 | US5502168 Polypeptides for malaria vaccines |
03/26/1996 | US5502167 CDR grafted humanised chimeric T-cell antibodies |
03/26/1996 | US5502037 Antitumor agents for procytotoxic drugs |
03/26/1996 | US5502022 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
03/26/1996 | US5501988 Cancer detection |
03/26/1996 | US5501987 Dual analyte immunoassay for methamphetamine and amphetamine |
03/26/1996 | US5501969 Bone disorders, antitumor |
03/26/1996 | US5501854 Comprising first and second portions having affinities for cellular target and bioactive molecules respectively; therapy, medical diagnosis |
03/26/1996 | CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues |
03/21/1996 | WO1996008722A1 Diagnostic test for proliferative senescence in immune cells |
03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
03/21/1996 | WO1996008571A1 Identification of dna-damaging substances by means of cell lines capable of overexpressing poly(adp-ribose)-polymerase |
03/21/1996 | WO1996008570A1 Expression and export technology of proteins as immunofusins |
03/21/1996 | WO1996008565A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
03/21/1996 | WO1996008564A1 Humanised antibody to integrin chain beta-1 |
03/21/1996 | WO1996008557A1 Human inositol monophosphatase h1 |
03/21/1996 | WO1996008516A1 PORCINE ANTIBODIES TO TNF-α(ALPHA) |
03/21/1996 | WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
03/21/1996 | WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
03/21/1996 | WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
03/21/1996 | WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
03/21/1996 | WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes |
03/21/1996 | WO1996008265A1 Corticotropin release inhibiting factor and methods of using same |
03/21/1996 | WO1996008231A1 Control of hair growth |
03/21/1996 | WO1996005309A3 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
03/21/1996 | WO1996002272A3 Treatment of autoimmune diseases |
03/21/1996 | DE4433130A1 Identifizierung von DNA-schädigenden Substanzen durch Poly(ADP-Ribose)-Polymerase überexprimierende Zellinien Identification of DNA-damaging substances by poly (ADP-ribose) polymerase-overexpressing cell lines |
03/21/1996 | CA2200097A1 Recombinant peptides derived from the mc3 anti-ba46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein |
03/21/1996 | CA2200085A1 Control of hair growth |
03/21/1996 | CA2200050A1 Diagnostic test for proliferative senescence in immune cells |
03/21/1996 | CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes |
03/21/1996 | CA2199749A1 Humanised antibody to integrin chain beta-1 |
03/21/1996 | CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
03/21/1996 | CA2199734A1 Corticotropin release inhibiting factor and methods of using same |
03/20/1996 | EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits |
03/20/1996 | EP0702082A1 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and dna base sequences encoding those sequences |
03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
03/20/1996 | EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
03/20/1996 | EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
03/20/1996 | EP0701573A1 Genetically engineered immunoglobulins |
03/20/1996 | EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
03/20/1996 | EP0701566A1 High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand |
03/20/1996 | EP0546032B1 Immobilization of organic macromolecules or biopolymers in a polymer membrane |
03/20/1996 | EP0456842B1 Medicinal application of m-csf |
03/20/1996 | EP0355140B1 Human monoclonal anti-hiv-i-antibodies |
03/20/1996 | CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
03/19/1996 | US5500363 Recombinant thermostable DNA polymerase from archaebacteria |
03/19/1996 | US5500362 Chimeric antibody with specificity to human B cell surface antigen |
03/19/1996 | US5500361 β-ketoacyl-ACP synthetase II genes from plants |
03/19/1996 | US5500349 Blood-coagulation factor XIIA β monoclonal antibody and immunoassay |
03/19/1996 | US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
03/19/1996 | US5500347 Diagnosis of cancerous tumors and determination of their origin |
03/19/1996 | US5500346 Monoclonal antibodies to human influx peptide transporter |
03/19/1996 | US5500345 Immunoassay |
03/19/1996 | US5500215 Immunology |
03/17/1996 | CA2158395A1 Coccidiosis poultry vaccine |
03/14/1996 | WO1996007915A1 Predictive test for hepatitis-b resistance |
03/14/1996 | WO1996007906A1 Screening method for periodontal disease |
03/14/1996 | WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
03/14/1996 | WO1996007745A2 Mycobacteria functional screening and/or expression vectors |
03/14/1996 | WO1996007740A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
03/14/1996 | WO1996007739A2 Interleukin-1 type 3 receptors |
03/14/1996 | WO1996007735A1 Novel deoxyribonuclease |